ALS Limited secures full ownership of Nuvisan Pharma
SYDNEY, AUSTRALIA: ALS Limited (ASX: ALQ) has announced the acquisition of the remaining 51% stake in Nuvisan Pharma Holding GmbH, a leading European contract research...
ALS Limited appoints Malcolm Deane as CEO and Managing Director
SYDNEY, AUSTRALIA: ALS Limited has today announced that following a comprehensive global search and selection process, the Board has appointed Malcolm Deane as the Managing...
ALS Limited buys 49% shares in NUVISAN for EUR 145 million
SYDNEY, AUSTRALIA: ALS Limited has bought an initial 49% shares in NUVISAN, a pharmaceutical testing business with operations in Germany and France, a news release...
ALS Limited announces acquisition of Americas-based Investiga
SYDNEY: ALS Limited announced the acquisition of Investiga, a pharmaceutical testing business with operations in Brazil and the east coast of the USA. Founded in...
ALS Limited
ALS Limited (ASX: ALQ) is a company headquartered in Brisbane, Australia, which provides testing, inspection, certification, and verification services out of over 370 sites across...